Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial-Reference-Cited by-同舟云学术

Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial

Published:2020-09-01 Issue:20 Volume:26 Page:5368-5379
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Multhoff Gabriele,Seier Sophie,Stangl Stefan,Sievert Wolfgang,Shevtsov Maxim^ORCID,Werner Caroline,Pockley A. Graham^ORCID,Blankenstein Christiane,Hildebrandt Martin,Offner Robert,Ahrens Norbert^ORCID,Kokowski Konrad,Hautmann Matthias^ORCID,Rödel Claus,Fietkau Rainer,Lubgan Dorota^ORCID,Huber Rudolf^ORCID,Hautmann Hubert^ORCID,Duell Thomas,Molls Michael,Specht Hanno,Haller Bernhard,Devecka Michal,Sauter Andreas^ORCID,Combs Stephanie E.

Funder

BMBF “Innovative Therapies

BMBF “Kompetenzverbund Strahlenforschung”

BMWi

German Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming natural killer cells for cancer therapy;Molecular Therapy;2024-09

2. Granzyme B-based CAR T cells block metastasis by eliminating circulating tumor cells;2024-03-19

3. Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME);Heliyon;2024-03

4. Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer;Frontiers in Oncology;2023-12-19

5. Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors;Frontiers in Immunology;2023-12-15